切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (11) : 877 -880. doi: 10.3877/cma.j.issn.1674-0785.2020.11.005

所属专题: 乳腺疾病 文献

专家论坛

乳腺癌筛查工作中妇幼保健院的角色和任务
吕艳丽1, 李毅1,()   
  1. 1. 101300 北京市顺义区妇幼保健院 北京儿童医院顺义妇儿医院乳腺中心
  • 收稿日期:2020-07-30 出版日期:2020-11-15
  • 通信作者: 李毅

Roles and tasks of health care hospital for women and children in breast cancer screening

Yanli Lv1, Yi Li1,()   

  1. 1. Breast Center, Shunyi District Health Care Hospital for Women and Children of Beijing Shunyi Women's and Children's Hospital of Beijing Children's Hospital, Beijing 101300, China
  • Received:2020-07-30 Published:2020-11-15
  • Corresponding author: Yi Li
引用本文:

吕艳丽, 李毅. 乳腺癌筛查工作中妇幼保健院的角色和任务[J]. 中华临床医师杂志(电子版), 2020, 14(11): 877-880.

Yanli Lv, Yi Li. Roles and tasks of health care hospital for women and children in breast cancer screening[J]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(11): 877-880.

乳腺癌是威胁女性健康和生命的最常见的恶性肿瘤。目前,乳腺癌诊疗领域具有规范的诊疗标准,通过筛查而早期发现并尽早治疗是乳腺癌防控工作的有效措施。国家非常重视慢性病防控工作,“健康中国2030”规划纲要提出到2030年,总体癌症5年生存率提高15%,其中乳腺癌生存率的提高至关重要。我国妇幼保健系统在长期实践中形成了“县、乡、村”三级妇幼卫生服务网络以及群防群控和临床诊疗相结合的有效模式,在开展乳腺癌筛查方面具有独特优势。北京市乳腺癌筛查工作开展10余年来,形成了妇幼保健院为主导的组织构架和筛查体系,在乳腺专科的引领下,筛查的技术水平不断提升。在卫生行政部门的支持下,妇幼保健院应利用管理和体系优势开展乳腺癌筛查相关研究,探索适合中国人群的乳腺癌筛查模式。

Breast cancer is the most common malignancy that threatens women's health and lives. Currently, clinical practice guidelines provide standards for breast cancer diagnosis and treatment. Early detection and treatment through screening are effective measures for breast cancer prevention and control. Chinese government attaches great importance to the prevention and control of chronic diseases. The "Healthy China 2030" planning outline proposes that by 2030, the overall 5-year survival of cancer will increase by 15%, in which the improvement of breast cancer patients' survival is crucial. China's health care system for women and children has formed an effective model in long-term practices, which contains a three-level health service network of "county-town-village", as well as the combination of group prevention & control and clinical diagnosis & treatment. Such operation model would have unique advantages in breast cancer screening project. In the past 10 years since the initiation of breast cancer screening in Beijing, an organizational structure and screening system led by health care hospitals for women and children has been formed. Under the leadership of breast specialty, the technical capacity of screening has been continuously improved. With the support of the health administration, the health care hospitals for women and children should utilize the advantages of management and system to carry out breast cancer screening related research and explore a suitable screening model for Chinese women.

1
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394‐424.
2
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
3
孙可欣, 郑荣寿, 顾秀瑛, 等. 2000-2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析 [J]. 中华预防医学杂志, 2018, 52(6): 567-572.
4
Liu Y, Zhang J, Huang R, et al. Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study [J]. Medicine (Baltimore), 2017, 96(15): e6641.
5
Aron JL, Prorok PC. An analysis of the mortality effect in a breast cancer screening study [J]. Int J Epidemiol, 1986, 15(1): 36-43.
6
Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography (Review) [J]. Cochrane Database of Systematic Reviews, 2013, 6: 56-58.
7
Kim Y, Jun JK, Choi KS, et al. Overview of the National Cancer screening programme and the cancer screening status in Korea [J]. Asian Pac J Cancer Prev, 2011, 12(3): 725-730.
8
Park JH. Cancer facts & figures in 2012 in the Republic of Korea [M]. Seoul: National Cancer Center, 2012.
9
Oshima A. A critical review of cancer screening programs in Japan [J]. Int J Technol Assess Health Care, 1994, 10(3): 346-358.
10
Ohnuki K. Mammographic screening for non-palpable breast cancer in Japan [J]. Breast Cancer, 2005, 12(4): 258-266.
11
Huang Y, Dai H, Song F, et al. Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women [J]. Sci Rep, 2016, 6: 39459.
12
Huang Y, Tong Z, Chen K, et al. Interpretation of breast cancer screening guideline for Chinese women [J]. Cancer Biol Med, 2019, 16(4): 825-835.
13
Dong H, Huang Y, Song F, et al. Improved performance of adjunctive ultrasonography after mammography screening for breast cancer among Chinese females [J]. Clin Breast Cancer, 2018, 18(3): e353-e361.
14
Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study [J]. Int J Cancer, 2015, 136(8): 1921-1930.
15
The GW Medical Faculty Associates. The mammovan mobile mammography providing breast screenings [EB/OL]. [2020-05-25].

URL    
16
McElfish PA, Su LJ, Lee JY, et al. Mobile mammography screening as an opportunity to increase access of rural women to breast cancer research studies [J]. Breast Cancer (Auckl), 2019, 13: 1178223419876296.
17
Linver MN, Osuch JR, Brenner RJ, et al. The mammography audit: a primer for the mammography quality standards act (MQSA) [J]. AJR Am J Roentgenol, 1995, 165(1): 19-25.
18
Perry N, Broeders M, de Wolf C, et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document [J]. Ann Oncol, 2008, 19(4): 614-622.
19
Yuan Y, Vu K, Shen Y, et al. Importance of quality in breast cancer screening practice-a natural experiment in Alberta, Canada [J]. BMJ Open, 2020, 10(1): e028766.
20
李毅, 吕艳丽, 赵越, 等. 不同组织模式下乳腺癌筛查结果分析 [J]. 中国癌症杂志, 2014, 24(12): 944-950.
21
吕艳丽, 赵越, 秦红风,等. 北京市顺义区5轮乳腺癌筛查结果分析 [J]. 现代预防医院, 2017, 44(8): 1437-1440, 1447.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 旺久, 陈军, 朱霞, 米玛央金, 赵胜, 陈欣林, 李建华, 王双. 山南市妇幼保健院开展胎儿系统超声筛查的效果分析[J]. 中华医学超声杂志(电子版), 2023, 20(07): 728-733.
[3] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[4] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[5] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[6] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[7] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[8] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[9] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[10] 熊倩, 罗凤. 乳腺癌患者术后康复现状与对策的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 372-374.
[11] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[12] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[13] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[14] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[15] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
阅读次数
全文


摘要